Paradoxical articular manifestations in patients with inflammatory bowel diseases treated with infliximab

Abstract

Paradoxical articular manifestations in IBD patients treated by anti-TNF are common, affecting more than 10% of patients. These events are generally mild and do not need discontinuation of anti-TNF therapy.